The role of caspase-3 activation in phencyclidine-induced neuronal death in postnatal rats

Neuropsychopharmacology

Volumn 32, Issue 5, 2007, Pages 1178-1194

  Wang, Cheng Z ^a   Johnson, Kenneth M ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Apoptosis; Caspase 3; Development; Neurodegeneration; Phencyclidine; Schizophrenia

Indexed keywords

CASPASE 3; CASPASE 3 INHIBITOR; PHENCYCLIDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CINGULATE GYRUS; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DNA CLEAVAGE; DNA DAMAGE; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME ACTIVITY; EXPERIMENTAL STUDY; FRONTAL CORTEX; HIPPOCAMPUS; IMMUNOCOMPETENT CELL; IMMUNOREACTIVITY; IN VITRO STUDY; NERVE DEGENERATION; NICK END LABELING; NONHUMAN; PARIETAL LOBE; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SILVER STAINING; THALAMUS;

AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BRAIN; CASPASE 3; CELL DEATH; DISEASE MODELS, ANIMAL; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; IN SITU NICK-END LABELING; MALE; NERVE DEGENERATION; ORGAN CULTURE TECHNIQUES; PHENCYCLIDINE; RATS; RATS, SPRAGUE-DAWLEY; SCHIZOPHRENIA; TIME FACTORS;

EID: 34247388039     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301202     Document Type: Article

References (72)

1. Adams B, Moghaddam B (1998). Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine. J Neurosci 18: 5545-5554.
2. Adams SM, de Rivero Vaccari JC, Corriveau RA (2004). Pronounced cell death in the absence of NMDA receptors in the developing somatosensory thalamus. J Neurosci 24: 9441-9450.
3. Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky EB, Orrenius S, Lipton SB et al (1995). Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15: 961-973.
4. Asimiadou S, Bittigau P, Felderhoff-Mueser U, Manthey D, Sifringer M, Pesditschek S et al (2005). Protection with estradiol in developmental models of apoptotic neurodegeneration. Ann Neurol 58: 266-276.
5. Benes FM, Berretta S (2001). GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacology 25: 1-27.
6. Benes FM, McSparren J, Bird ED, SanGiovanni JP, Vincent SL (1991). Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch Gen Psychiatry 48: 996-1001.
7. Benes FM, Vincent SL, Todtenkopf M (2001). The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 50: 395-406.
8. Carlsen J, De Olmos JS (1981). A modified cupric-silver technique for the impregnation of degenerating neurons and their processes. Brain Res 208: 426-431.
9. Choi DW (1985). Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neuroscience Lett 58: 293-297.
10. Clinton SM, Meador-Woodruff JH (2004). Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophr Res 69: 237-253.
11. Cohen GM (1997). Caspases: the executioners of apoptosis. Biochem J 326: 1-16.
12. Cosgrove J, Newell TG (1991). Recovery of neuropsychological functions during reduction in use of phencyclidine. J Clin Psychiatry 47: 159-169.
13. Dzietko M, Felderhoff-Mueser U, Sifringer M, Krutz B, Bittigau P, Thor F et al (2004). Erythropoietin protects the developing brain against N-methyl-D-aspartate receptor antagonist neurotoxicity. Neurobiol Dis 15: 177-187.
14. Fischer U, Jänicke RU, Schulze-Osthoff K (2003). Many cuts to ruin: a comprehensive update of caspase substrates. Cell Death Differ 10: 76-100.
15. Fiske BK, Brunjes PC (2001). NMDA receptor regulation of cell death in the rat olfactory bulb. J Neurobiol 47: 223-232.
16. Fix AS, Horn JW, Wightman KA, Johnson CA, Long GG, Storts RW et al (1993). Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Exp Neurol 123: 204-215.
17. Gavrieli Y, Sherman Y, Ben-Sasson SA (1992). Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 119: 493-501.
18. Gould E, Cameron HA, McEwen BS (1994). Blockade of NMDA receptors increases cell death and birth in the developing rat dentate gyrus. J Comp Neurol 340: 551-565.
19. Hansen HH, Briem T, Dzietko M, Sifringer M, Voss A, Rzeski W et al (2004). Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol Dis 16: 440-453.
20. Hardingham GE, Bading H (2003). The Yin and Yang of NMDA receptor signaling. Trends Neurosci 26: 81-89.
21. Harris LW, Sharp T, Gartlon J, Jones DN, Harrison PJ (2003). Long-term behavioral, molecular and morphological effects of neonatal NMDA receptor antagonism. Eur J Neurosci 18: 1706-1710.
22. Harrison PJ, Weinberger DR (2005). Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry 10: 40-68.
23. Hoffman PL, Rabe CS, Moses F, Tabakoff B (1989). N-methyl- D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J Neurochem 52: 1937-1940.
24. Hu BR, Liu CL, Ouyang Y, Blomgren K, Siesjo BK (2000). Involvement of caspase-3 in cell death after hypoxia-ischemia declines during brain maturation. J Cereb Blood Flow Metab 20: 1294-1300.
25. Hwang JY, Kim YH, Ahn YH, Wie MB, Koh JY (1999). N-Methyl- D-aspartate receptor blockade induces neuronal apoptosis in cortical culture. Exp Neurol 159: 124-130.
26. Ikonomidou C, Bittigau P, Ishimaru M, Wozniak DF, Koch C, Genz K et al (2000). Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 287: 1056-1060.
27. Ikonomidou C, Bosch F, Miksa M, Bittigau P, Vockler J, Dikranian K et al (1999). Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283: 70-74.
28. Jarskog LF, Glantz LA, Gilmore JH, Lieberman JA (2005). Apoptotic mechanisms in the pathophysiology of schizophrenia. Prog Neuro- Psychopharmacol Biol Psych 29: 846-858.
29. Javitt DC, Zukin SR (1991). Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148: 1301-1308.
30. Kasai K, Iwanami A, Yamasue H, Kuroki N, Nakagome K, Fukuda M (2002). Neuroanatomy and neurophysiology in schizophrenia. Neurosci Res 43: 93-110.
31. Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R (2003). NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development. Psychopharmacology (Berl) 169: 215-233.
32. Kudryashov IE, Onufriev MV, Kudryashova IV, Gulyaeva NV (2001). Periods of postnatal maturation of hippocampus: synaptic modifications and neuronal disconnection. Brain Res Dev Brain Res 132: 113-120.
33. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H et al (1996). Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384: 368-372.
34. Lewis DA (2000). GABAergic local circuit neurons and prefrontal cortical dysfunction in schizophrenia. Brain Res Brain Res Rev 31: 270-276.
35. Lipska BK (2004). Using animal models to test a neurodevelopmental hypothesis of schizophrenia. J Psychiatry Neurosci 29: 282-286.
36. Lodge D, Johnson KM (1990). Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 11: 81-86.
37. Lovinger DM, White G, Weight FF (1989). Ethanol inhibits NMDA-activated ion current in hippocampal neurons. Science 243: 1721-1724.
38. Luby ED, Cohen BD, Rosenbaum G, Gottlieb JS, Kelley R (1959). Study of a new schizophrenomimetic drug; sernyl. AMA Arch Neurol Psychiatry 81: 363-369.
39. McInnis J, Wang C, Anastasio N, Hultman M, Ye Y-P, Salvemini D et al (2002). The role of superoxide and NF-κB signaling in N-methyl-D-aspartate-induced necrosis and apoptosis. J Pharmacol Exp Ther 301: 478-487.
40. Meli E, Pangallo M, Picca R, Baronti R, Moroni F, Pellegrini-Giampietro D (2004). Differential role of poly(ADP-ribose) polymerase-1 in apoptotic and necrotic neuronal death induced by mild or intense NMDA exposure in vitro. Mol Cell Neurosci 25: 172-180.
41. Monti B, Contestabile A (2000). Blockade of the NMDA receptor increases developmental apoptotic elimination of granule neurons and activates caspases in the rat cerebellum. Eur J Neurosci 12: 3117-3123.
42. Noraberg J, Kristensen BW, Zimmer J (1999). Markers for neuronal degeneration in organotypic slice cultures. Brain Res Brain Res Protoc 3: 278-290.
43. Nowoslawski L, Klocke BJ, Roth KA (2005). Molecular regulation of acute ethanol-induced neuron apoptosis. J Neuropathol Exp Neurol 64: 490-497.
44. Olney JW (2002). New insights and new issues in developmental neurotoxicology. Neurotoxicology 23: 659-668.
45. Olney JW, Farber NB (1995). Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry 52: 998-1007.
46. Olney JW, Ho OL, Rhee V (1971). Cytotoxic effects of acidic and sulphur containing amino acids on the infant mouse central nervous system. Exp Brain Res 14: 61-76.
47. Olney JW, Labruyere J, Price MT (1989). Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244: 1360-1362.
48. Olney JW, Newcomer JW, Farber NB (1999). NMDA receptor hypofunction model of schizophrenia. J Psychiatric Res 33: 523-533.
49. Olney JW, Tenkova T, Dikranian K, Muglia LJ, Jermakowicz WJ, D'Sa C et al (2002). Ethanol-induced caspase-3 activation in the in vivo developing mouse brain. Neurobiol Dis 9: 205-219.
50. Paxinos G, Watson C (1998). The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press, Inc.: San Diego, California, USA (Plate 10-14, 81-82).
51. Rapoport JL, Addington AM, Frangou S, Psych MR (2005). The neurodevelopmental model of schizophrenia: update 2005. Mol Psychiatry 10: 434-449.
52. Sattler R, Tymianski M (2001). Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol Neurobiol 24: 107-129.
53. Scallet AC, Schmued LC, Slikker W, Grunberg N, Faustino PJ, Davis H et al (2004). Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicol Sci 81: 364-370.
54. Sharp FR, Butman M, Aardalen K, Nickolenko J, Nakki R, Massa SM et al (1994). Neuronal injury produced by NMDA antagonists can be detected using heat shock proteins and can be blocked with antipsychotics. Psychopharmacol Bull 30: 555-560.
55. Sherwood NM, Timiras PS (1970). A Stereotaxic Atlas of the Developing Rat Brain. University of California Press: Berkeley.
56. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD et al (1985). Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85.
57. Stefani MR, Moghaddam B (2005). Transient N-methyl-D- aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biol Psychiatry 57: 433-436.
58. Stefanis L, Park DS, Yan CY, Farinelli SE, Troy CM, Shelanski ML et al (1996). Induction of CPP32-like activity in PC12 by withdrawal of trophic support. Dissociation from apoptosis. J Biol Chem 271: 30663-30671.
59. Stoppini L, Buchs PA, Muller D (1991). A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37: 173-182.
60. Takadera T, Matsuda I, Ohyashiki T (1999). Apoptotic cell death and caspase-3 activation induced by N-methyl-D-aspartate receptor antagonists and their prevention by insulin-like growth factor I. J Neurochem 73: 548-556.
61. Takadera T, Ohyashiki T (2004). Glycogen synthase kinase-3 inhibitors prevent caspase-dependent apoptosis induced by ethanol in cultured rat cortical neurons. Eur J Pharmacol 499: 239-245.
62. Turner CP, Pulciani D, Rivkees SA (2002). Reduction in intracellular calcium levels induces injury in developing neurons. Exp Neurol 178: 21-32.
63. Wang C, Fridley J, Johnson KM (2005). The role of NMDA receptor upregulation in phencyclidine-induced cortical apoptosis in organotypic culture. Biochem Pharmacol 69: 1373-1383.
64. Wang C, McInnis J, Ross-Sanchez M, Shinnick-Gallagher P, Wiley JL, Johnson KM (2001). Long-term behavioral and neurodegenerative effects of postnatal phencyclidine administration: implications for schizophrenia. Neuroscience 107: 535-550.
65. Wang CZ, Johnson KM (2005). Differential effects of acute and subchronic administration on phencyclidine-induced neurodegeneration in the postnatal rat. J Neurosci Res 81: 284-292.
66. Weinberger DR (1997). The biological basis of schizophrenia: new directions. J Clin Psychiatry 58(Suppl 10): 22-27.
67. West MJ (1993). New stereological methods for counting neurons. Neurobiol Aging 14: 275-285.
68. Wiley JL, Buhler KG, Lavecchia KL, Johnson KM (2003). Pharmacological challenge reveals long-term effects of postnatal phencyclidine on delayed spatial alternation in rats. Prog Neuropsychopharmacol Biol Psychiatry 27: 867-873.
69. 2+ deficiency. J Neurochem 85: 525-533.
70. Young C, Klocke BJ, Tenkova T, Chio J, Labruyere J, Qin Y-Q et al (2003). Ethanol-induced neuronal apoptosis in vivo requires BAX in the developing mouse brain. Cell Death Differ 10: 1148-1155.
71. Young C, Roth KA, Klocke BJ, West T, Holtzman DM, Labruyere J et al (2005). Role of caspase-3 in ethanol-induced developmental neurodegeneration. Neurobiol Dis 20: 608-614.
72. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR (1993). The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 19: 641-652.